VLA 0.00% $1.75 viralytics limited

Cancer study: Immunotherapy before surgery could dramatically...

  1. 73 Posts.
    lightbulb Created with Sketch. 1
    Cancer study: Immunotherapy before surgery could dramatically improve cancer survival rates

    Posted 21 minutes agoTue 6 Dec 2016, 8:26am
    Photo: Malignant breast cancer cells, with the cancer killing about half a million people worldwide a year. (Supplied)
    Related Story: 'It would save a lot of lives': Rare cancer patients push for better medication access
    Related Story: 'Personalised' radiation trial offers hope to skin cancer patients

    Map: Brisbane 4000
    Reversing the order of treatment for patients with certain cancers could increase survival rates by up to 60 per cent, Queensland scientists have found during an experiment on mice.
    Researchers at the QIMR Berghofer Medical Research Institute trialled giving immunotherapy drugs to mice with breast cancer before surgery, rather than after.
    Survival rates are usually very low, but about half of the mice treated in this order were cured.
    Dr Michele Teng, who led the study, said if they results were replicated in humans it could lead to widespread changes in oncology practices.
    "To our surprise, when we gave mice a combination of two immunotherapy drugs before surgery, between 40 and 60 per cent were cured of triple-negative breast cancer," she said.
    "It appears that this therapy destroyed any cancer cells that had spread to other parts of the body and stopped the cancer from returning."
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.